Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,832
Out of 4,839 analysts
18
Total ratings
8.33%
Success rate
-41.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Life Sciences | Initiates: Buy | $18 | $2.02 | +791.09% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $21.55 | -21.11% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $4.18 | +713.40% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $104.35 | -8.96% | 2 | Nov 1, 2022 | |
| SAGE Sage Therapeutics | Initiates: Hold | $41 | $6.61 | +520.27% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $0.68 | +193.69% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $33 | $0.27 | +12,099.63% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $1.65 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $2.25 | +1,322.22% | 4 | Dec 16, 2020 |
Atai Life Sciences
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $2.02
Upside: +791.09%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $21.55
Upside: -21.11%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $4.18
Upside: +713.40%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $104.35
Upside: -8.96%
Sage Therapeutics
Nov 1, 2022
Initiates: Hold
Price Target: $41
Current: $6.61
Upside: +520.27%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $0.68
Upside: +193.69%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $33
Current: $0.27
Upside: +12,099.63%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.65
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $2.25
Upside: +1,322.22%